Skip to main content

Transdermal Estrogen as Preferred Prescription for Perimenopausal Symptom Relief, and the Role of Progesterone

  • Chapter
  • First Online:
  • 1422 Accesses

Abstract

In light of the history of estrogen use and the studies of HT, up to and especially the Women’s Health Initiative (2002) results regarding orally administered HT, the prescription of transdermal HT combines the most efficacious use of estrogen replacement with the safest route of administration, and when prescribed to treat an individual woman’s menopause symptoms using bio-identical hormones, is the new gold standard for menopausal hormone replacement therapy.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Bibliography

  1. Bäckström T, Haage D, Löfgren M, et al. Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience. 2011;191:46–54.

    Article  PubMed  Google Scholar 

  2. Chu MC, Cosper P, Nakhuda GS, Lobo RA. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Fertil Steril. 2006;86:1669–75.

    Article  PubMed  CAS  Google Scholar 

  3. Kublickiene K, Luksha L. Gender and the endothelium. Pharmacol Rep. 2008;60: 49–60.

    PubMed  CAS  Google Scholar 

  4. Olié V, Canonico M, Scarabin P-V. Postmenopausal hormone therapy and venous thromboembolism. Thromb Res. 2011;127 suppl 3:S26–9.

    Article  PubMed  Google Scholar 

  5. Wharton W, Baker LD, Gleason CE, et al. Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer’s disease: results of a randomized controlled trial. J Alzheimers Dis. 2011;26(3): 495–505.

    PubMed  CAS  Google Scholar 

  6. Wroolie TE, Kenna HA, Williams KE, et al. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β estradiol versus conjugated equine estrogens. Am J Geriatr Psychiatry. 2011;19:792–802.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sherif, K. (2013). Transdermal Estrogen as Preferred Prescription for Perimenopausal Symptom Relief, and the Role of Progesterone. In: Hormone Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6268-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6268-2_6

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6267-5

  • Online ISBN: 978-1-4614-6268-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics